ID1 Protein and Melanoma Survival
Author Information
Author(s): Straume O, Akslen L A
Primary Institution: The Gade Institute, Section for Pathology, University of Bergen, Haukeland University Hospital, Bergen, Norway
Hypothesis
The study investigates the role of ID1 protein expression in malignant melanoma and its association with patient survival and tumor characteristics.
Conclusion
Strong ID1 expression is linked to thicker tumors and poorer patient survival in malignant melanoma.
Supporting Evidence
- Strong ID1 expression was significantly associated with increased tumor thickness.
- Patients with high ID1 expression had significantly reduced survival.
- ID1 expression was related to the presence of BRAF mutations.
Takeaway
This study found that when a protein called ID1 is present in high amounts in melanoma, it usually means the cancer is worse and patients may not live as long.
Methodology
The study used immunohistochemistry on tissue microarrays to evaluate ID1 expression in 119 cases of nodular melanoma and related it to various tumor markers and patient survival.
Limitations
The study focused only on nodular melanomas and did not explore other melanoma types.
Participant Demographics
The study included cases from Hordaland County, Norway, with no significant differences in sex, anatomic site, or stage.
Statistical Information
P-Value
0.006
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website